Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
REGNCash Flow Performance
Trending higher, strong compound growth.
Left:
|||
Free cash flow yield
Latest
4.77%
↑ 11% above average
Average (9y)
4.28%
Historical baseline
Range
High:9.78%
Low:1.04%
CAGR
+18.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 4.77% | +21.8% |
| 2023 | 3.91% | -31.7% |
| 2022 | 5.73% | -41.5% |
| 2021 | 9.78% | +153.8% |
| 2020 | 3.85% | -21.0% |
| 2019 | 4.88% | +15.4% |
| 2018 | 4.23% | +78.0% |
| 2017 | 2.37% | +4.0% |
| 2016 | 2.28% | +118.7% |
| 2015 | 1.04% | - |